LEXX Stock Analysis: Buy, Sell, or Hold?
LEXX - Lexaria Bioscience Corp. Common Stock
$4.75
4.36 (1114.83%)
▲
5d:
+810.83%
30d:
+748.06%
90d:
+567.79%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 13, 2026
0d
Get Alerted When LEXX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: LEXX is 214.6% above its trading range ($1.51). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: LEXX is 214.6% above its trading range ($1.51). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: LEXX is currently trading at $4.75, which is considered extended relative to its 30-day fair value range of $-0.08 to $1.51.
Technical Outlook: Technically, LEXX is showing sideways momentum. Immediate support is located at $0.35, while resistance sits at $5.90. The stock is showing strong short-term momentum, up 1114.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.50 (+1005.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEXX is showing sideways momentum. Immediate support is located at $0.35, while resistance sits at $5.90. The stock is showing strong short-term momentum, up 1114.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.50 (+1005.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.08 -
$1.51
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price significantly overextended (+214.6% above its trading range)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+1114.8%)
- BULLISH: Trading 1005.3% below Wall St target ($52.50)
- WARNING: Recommendation downgraded due to 214.6% overvaluation
Trading Range Analysis
30-Day Trading Range
$-0.08 -
$1.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.35
Resistance Level
$5.90
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.02
Wall Street Target
$52.50
(+1005.3%)
Revenue Growth (YoY)
-88.5%
Share & Embed Analysis
Last updated: August 03, 2026 9:45 PM ET
Data refreshes hourly during market hours. Next update: 10:45 PM
Data refreshes hourly during market hours. Next update: 10:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEXX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
